MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0075828
Reelabs Private Limited - life sciences in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.69 Cr
▼ 11% YoY
Net profit · FY 2024
₹1.26 Cr
Net margin 7.1%
EBITDA · FY 2024
₹3.48 Cr
EBITDA margin 19.7%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹2.23 Cr
Issued & subscribed
Open charges
₹20.5 Cr
Satisfied ₹35 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
45
Provident fund records
About Reelabs Private Limited
Data last updated:
Reelabs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 23 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2009PTC190531. Its GSTIN is 27AAECR2744P1ZV (Maharashtra).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.23 Cr. It was formerly known as Ree Laboratories Private Limited. It is led by directors including Sunil Haripant Pophale (Managing Director) and Rohit Ramchandra Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor K.K. Chambers Sir.P.T.Road Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.69 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.26 Cr (net margin 7.1%) and EBITDA of ₹3.48 Cr (EBITDA margin 19.7%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 22% over five years.
The company has about 45 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: ReeLabs and Reelabs Wellness. As per MCA filings, the company has open charges of ₹20.5 Cr and satisfied charges of ₹35 Cr on record. Court records list 10 cases involving the company, including 4 filed by the company and 6 filed against it; 6 cases are pending. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Miltenyi Biotec India Private Limited with revenue of ₹19.1 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 6 micro and small suppliers.
Reelabs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0075828). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reelabs.com.
Company Details of Reelabs Private Limited
CIN U85100MH2009PTC190531
Registration Number 190531
Incorporation Date 23 February 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0075828
Name History of Reelabs Private Limited
Reelabs has undergone 2 name changes throughout its history. The company was previously known as Ree Labs Private Limited, and Ree Laboratories Private Limited. The current legal name is Reelabs Private Limited.
| Company Name | Status |
|---|---|
| Reelabs Private Limited | Current |
| Ree Labs Private Limited | Previous |
| Ree Laboratories Private Limited | Previous |
Key People
Sunil Haripant Pophale Managing Director Rohit Ramchandra Kulkarni Director Abhijit Shyamsunder Bopardikar Director Recognitions & Rankings of Reelabs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1st Floor K.K. Chambers Sir.P.T.Road Fort, Mumbai, Maharashtra, India – 400001
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Reelabs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Reelabs Private Limited
Reelabs operates two associated brands: ReeLabs and Reelabs Wellness. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers stem cell banking from various sources and therapy for medical treatments. | reelabs.com | |
| Offers nutraceuticals, hair, and skin care products for health and wellness improvement. | reelabswellness.com |
Business Activity of Reelabs Private Limited
The main business activity of Reelabs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Reelabs Private Limited FY 2025 filings available
Reelabs Private Limited reported revenue of ₹17.69 Cr (down 11% YoY) for FY 2024.
Revenue · FY 2024
₹17.69 Cr ▼ 11%
Net profit · FY 2024
₹1.26 Cr margin 7.1%
EBITDA · FY 2024
₹3.48 Cr margin 19.7%
Compounded Annual Growth Rate (CAGR) of Reelabs Private Limited
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 25%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 52%
5 years · compounded
▲ 19%
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reelabs Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.48 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reelabs Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reelabs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Reelabs Private Limited
Reelabs has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Ramchandra Kulkarni Also directs: Satiava Healthcare LLP, R K Ubiquitous Strategic Advisors and Consultants LLP, Ibhaan Pharmaceuticals Private Limited and 1 more | Director | 23 Feb 2009 | 17 Years 7 Months | Current |
| Abhijit Shyamsunder Bopardikar Also directs: Satiava Healthcare LLP, Ibhaan Pharmaceuticals Private Limited | Director | 23 Feb 2009 | 17 Years 7 Months | Current |
| Sunil Haripant Pophale | Managing Director | 23 Feb 2009 | 17 Years 7 Months | Current |
Peer Comparison of Reelabs Private Limited
Reelabs Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Miltenyi Biotec India Private Limited | ₹19.1 Cr (FY 2025) | •••• | •••• | 751.0% | •••• | Telangana, India |
| Accura Bio Q Private Limited | ₹18.8 Cr (FY 2025) | •••• | •••• | 104.0% | •••• | Medak, Telangana, India |
| Green Genome India Private Limited | ₹18.54 Cr (FY 2025) | •••• | •••• | 806.0% | •••• | New Delhi, Delhi, India |
| Nucleome Informatics Private Limited | ₹18.23 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Hyderabad, Telangana, India |
| Stempeutics Research Private Limited | ₹17.88 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Bengaluru, Karnataka, India |
| Reelabs Private Limited this company | ₹17.69 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Mumbai, Maharashtra, India |
| Envozyme Technologies Private Limited | ₹17.43 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Hyderabad, Telangana, India |
| Cellutions Biostorage Private Limited | ₹17.29 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Kanchipuram, Tamil Nadu, India |
| S4 Research Private Limited | ₹17.22 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Juniper Life Sciences Private Limited | ₹17.18 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Bengaluru, Karnataka, India |
| Gangabishan Bhikulal Investment and Trading Limited | ₹16.96 Cr (FY 2023) | •••• | •••• | 20055.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Reelabs by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Reelabs Private Limited
Reelabs Private Limited is audited by S R RAHALKAR AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R RAHALKAR AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Reelabs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Reelabs Private Limited
Open charges
₹20.5 Cr
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹20.5 Cr | Open |
| 17 Nov 2023 | Others | ₹15 Cr | Satisfied |
| 15 Mar 2022 | Others | ₹5 Cr | Satisfied |
| 15 Mar 2022 | Others | ₹5 Cr | Satisfied |
| 29 Dec 2014 | Nkgsb Cooperative Bank Limited | ₹5 Cr | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Reelabs Private Limited
Reelabs Private Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022.
Total deals
5
Funding rounds
2
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹85 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2015 | Rights issue | ₹3.33 Cr | Investors: 3 individuals |
| Mar 2012 | Funding round | ₹30 Lakh | Investors: 3 individuals |
| Mar 2010 | Funding round | ₹55 Lakh | Investors: 3 individuals |
Premium access
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Reelabs Private Limited
Reelabs Private Limited has 10 court cases on record: 4 filed by Reelabs, 6 filed against it. 6 cases are pending and 4 are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Total cases
10
Filed by the company
4
Filed against the company
6
Pending
6
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 4 | 4 |
| District courts | 2 | 2 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed against the company by Fortis Hospitals Limited | Pending |
| Bombay High Court | Court case (CARBP) | Filed against the company by an individual | Pending |
| Bombay High Court | Arbitration matter | Filed by the company against an individual | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against an individual | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against an individual | Pending |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Reelabs Private Limited
Reelabs Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Indo Amines Limited | •••• | •••• | •••• |
| Genetix Biotech Asia Limited | •••• | •••• | •••• |
| National Chemical Co | •••• | •••• | •••• |
| Salicylates & Chemicals Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Reelabs Private Limited
Reelabs Private Limited has a workforce of 45 employees as of Apr 08, 2024.
Employee count
45
Active EPFO establishments
1
Employee growth
-4.26%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Reelabs Private Limited
Reelabs Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Abhijit Shyamsunder Bopardikar was appointed as Director on 23 Feb 2009.
AGM
Reelabs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Reelabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 17 Nov 2023 via Charge ID 100823208 with Others was fully satisfied on 14 Nov 2024.
Charges
A charge with Others amounted to Rs. 20.50 Cr with Charge ID 100988188 was registered on 30 Sep 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100823208 was registered on 17 Nov 2023.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100565701 with Others was fully satisfied on 25 Oct 2023.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100565703 with Others was fully satisfied on 25 Oct 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100565701 was registered on 15 Mar 2022.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100565703 was registered on 15 Mar 2022.
Charges
A charge registered on 29 Dec 2014 via Charge ID 10544602 with Nkgsb Cooperative Bank Limited was fully satisfied on 31 Jan 2022.
Charges
A charge registered on 24 Dec 2014 via Charge ID 10544450 with Nkgsb Cooperative Bank Limited was fully satisfied on 31 Jan 2022.
Charges
A charge with Nkgsb Cooperative Bank Limited amounted to Rs. 5.00 Cr with Charge ID 10544602 was registered on 29 Dec 2014.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Reelabs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reelabs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Reelabs Private Limited
Reelabs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECR2744P1ZV | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reelabs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Reelabs Private Limited
Frequently Asked Questions about Reelabs Private Limited
Reelabs is an active private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 23 February 2009 (17+ years old) and is registered under CIN U85100MH2009PTC190531.
Reelabs reported revenue of ₹17.69 Cr for FY 2024 (down 11% YoY).
Reelabs has 3 current directors:
- Sunil Haripant Pophale - Managing Director
- Rohit Ramchandra Kulkarni - Director
- Abhijit Shyamsunder Bopardikar - Director
Reelabs reported a net profit of ₹1.26 Cr (net margin 7.1%) and EBITDA of ₹3.48 Cr (EBITDA margin 19.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Reelabs is -25% over three years and 22% over five years. In the latest year (FY 2024) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Reelabs is 27AAECR2744P1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reelabs is U85100MH2009PTC190531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reelabs has 10 court cases on record: 4 filed by the company and 6 filed against it. 6 are pending. Most are in the high courts.
Reelabs was incorporated on 23 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Reelabs has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022.
The peers of Reelabs by revenue are Miltenyi Biotec India Private Limited, Accura Bio Q Private Limited, Green Genome India Private Limited, Nucleome Informatics Private Limited, Stempeutics Research Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Abhijit Shyamsunder Bopardikar was appointed as Director on 23 Feb 2009. Rohit Ramchandra Kulkarni was appointed as Director on 23 Feb 2009. Sunil Haripant Pophale was appointed as Managing Director on 23 Feb 2009.